Anti-NGAL (rat)|肝肾功能|西宝生物科技（上海）股份有限公司-咨询电话：400-021-8158

当前位置:首页 » 产品中心 » 免疫学 » 抗原抗体 » 肝肾功能 » Anti-NGAL (rat)

prevnext

查看全部大图

Anti-NGAL (rat)

货号：ABS 039-08-02
包装：200 ug

别名：binds rat NGAL (neutrophil gelatinase-associated lipocalin)
品牌：Bioporto

ABS 039-08 Anti-NGAL (rat) 是一种鼠抗中性粒细胞明胶酶载脂蛋白(NGAL)单克隆抗体，主要应用于酶联免疫吸附试验(ELISA)和免疫组织化学(IHC)。4-8oC避光保存。

*西宝提示：我司所销售的化学试剂、原料等所有产品（包括但不限于抗生素类、蛋白质类、试剂盒类产品等）仅限用于科学研究用途，不得作用于人体。

订购热线：400-021-8158

产品详情质检信息

Cat. No.	ABS 039-08
Product name	Anti-NGAL (rat)
Description	Mouse monoclonal antibody
Specificity	ABS 039-08 binds rat NGAL (neutrophil gelatinase-associated lipocalin)
Immunogen	Recombinant rat NGAL precursor
Application	ELISA, IHC
Species reactivity (positive)	Rat
Species reactivity (negative)	Human, pig, dog, mouse
Subclass	IgG1/k
Clone number	8
Epitope	Not determined
Content	Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.
Purification	Protein-A purified
Form	Liquid
Solvent	0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide
Storage	4-8ºC without exposure to light. No precautions necessary during handling.
Target	Rat NGAL, so called because it is the ortholog of human neutrophil gelatinase-associated lipocalin (NGAL), is also called lipocalin 2, 25-kDa alpha 2-microglobulin-related protein / neu-related lipocalin. It is expressed by neutrophils and various epithelial cells, including tubular cells of the kidney. It is involved in physiological processes such as the binding of siderophore iron and tissue growth and regeneration. It is up-regulated in a variety of pathological situations including infection, inflammation, renal injury and certain adenocarcinomas.
Application 1	ELISA ABS 039-08 binds free rat NGAL in solution.
Application 2	IHC ABS 039-08 reacts with rat NGAL, when used in Immunohistochemistry. (1)

	NGAL immunostaining in kidney, Formalin-fixed, paraffin-embedded tissue sections of cortical epithelial cells in the S1/S2 segments (proximal convoluted tubules) following DXR-induced acute kidney injury. Top panel, saline treatment; bottom panel, DXR treatment; X630 (1).
Reference	1. Zhang J, Ohm J,Vaidya V, Espandiari P, Knapton A, Goering P, Brown R, Bonventre J, Herman E (2009) NGAL Expression in Kidney of Spontaneously Hypertensive Rats (SHR) Treated with Doxorubicin (DXR) Alone or Combined with Dexrazoxane (DRZ) (Presented at Tox Expo 2009)